Egypt's sugar plant, the biggest in the world, to produce 900,000 tons    Egypt's unemployment rate drops to 7.2%    Egypt's exports of food industries increase 5% in Q1    Egypt-first to have new climate targets ahead of UN summit    Egypt uncovers official logo for COP27    Ukrainian people say goodbye to Leonid Kravchuk – first elected president    Noura Al-Mutair – first Gulf female boxer in World Championships    Egypt unveils 50 pound coin minted to mark Avenue of Sphinxes grand reopening    Canada's Robert Oliphant starts Egypt, Morocco visit today    Liverpool fans: "You'll Never Walk Alone" to Cristiano Ronaldo    Hot, rainy weather hits Egypt this week    COVID-19 in Egypt: infections fall to 124 cases last week    Realme announces Global Photography Contest 2022    Egypt to play key role in integrating water, climate issues globally – World Bank official    AstraZeneca to boost Egypt investment 50% in three years    Egypt's telecoms regulator announces working hours for holy month of Ramadan    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    Ethiopia halts work at its embassy in Egypt for 'economic reasons'    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

A question of trust
Published in Ahram Online on 13 - 07 - 2021

Egypt is producing the Sinovac coronavirus vaccine through the state-owned Egyptian Holding Company for Biological Products and Vaccines (VACSERA), and aims to manufacture 80 million doses by the end of 2021. The Sinovac vaccine was approved by the World Health Organisation (WHO) for emergency use on 1 June, and by the Egyptian Drug Authority (EDA) in April.
Around 2.4 million doses of the locally manufactured Sinovac vaccine will be available in vaccination centres nationwide by the end of this month, says Heath Ministry Spokesperson Khaled Megahed, and Egypt expects to receive shipments of raw materials sufficient to produce 7.5 million additional doses soon.
"I am reluctant to take the vaccine, whether it is manufactured locally or abroad," Mahmoud Helmi, a 31-year-old engineer, told Al-Ahram Weekly. "All the time there are rumours regarding the possible side effects, and I've become obsessed by the idea that the vaccine might kill me."
Helmi's reaction may be extreme, but it chimes in with that of large swathes of the population who believe it is too early to judge if the vaccines will have a long-term effect on their health.
Others doubt the efficacy of locally produced vaccines. "We have been raised to trust international products over local ones, and Western products over Chinese," says Mustafa Mabrouk, a programmer.
Islam Anan, an epidemics specialist and a pharmaeconomics lecturer at Misr International University, told the Weekly that Chinese vaccines undergo the same clinical testing as other vaccines.
"For any vaccine to be approved by an international or regional health organisation it must pass several clinical tests which, once the vaccine is imported, are then repeated in Egypt," says Anan.
Sinovac is an inactivated vaccine. Its easy storage requirements make it "very manageable, and particularly suitable" for low-resource settings, says the WHO. It prevents symptomatic disease in 51 per cent of those vaccinated, and severe Covid-19 in 100 per cent of the studied population. WHO recommends Sinovac-Corona Vac vaccine for use in adults 18 years and older.
Anan stresses that for a company to allow the manufacture of its vaccine in another country requires medical technology transfer, and the specifications of the product must be the same as that produced in the home country.
"No international company will sacrifice its reputation by reproducing a product bearing its name without standard specifications," says Anan. He notes that thousands of medicines are produced in Egypt either in local plants of international pharmaceutical companies or reproduced in Egyptian drug factories.
Mohamed Hamza, 36, says he will not be taking the Chinese vaccine because his job requires him to travel. "I am going to Kuwait soon and it hasn't not yet recognised Chinese vaccines. I want to take the AstraZeneca vaccine."
Mohamed Hamdi, 38, who travels between Saudi Arabia, where he works, and France and Egypt, where his wife and family lives, has similar concerns. "Neither France nor Saudi Arabia accept Chinese vaccinations," he says.
Though the WHO has approved China's two vaccines, a majority of countries has yet to follow suit.
"The still not recognised vaccines, especially the Chinese ones, will soon be within the loop. It is all about politics," insists Anan.
The US Food and Drug Administration (FDA) has yet to approve the Chinese vaccine which means, Anan explains, that countries that have traditionally depended on the FDA's lead, are also delaying approval. But the delays, he argues, have nothing to do with the effectiveness of the vaccine. What they do mean, however, is that Egypt needs to continue importing vaccines for those who wish to travel.
Egypt, which started its vaccination campaign early this year, has imported millions of doses of the WHO-approved British AstraZeneca vaccine, the Chinese vaccines Sinopharm, and the non-WHO approved Russian Sputnik V.
"During the last few weeks Egypt has imported two million doses of the Sinovac and Sputnik V vaccines. At the end of this week, we will receive shipments of the AstraZeneca and Johnson & Johnson vaccines as well as two million doses of the Pfizer vaccine," says Megahed.
On 12 July, the WHO reported that 4.9 million doses had been administered in Egypt which has a population of 102 million.

*A version of this article appears in print in the 15 July, 2021 edition of Al-Ahram Weekly.

Clic here to read the story from its source.